ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OLMA Olema Pharmaceuticals Inc

9.06
0.33 (3.78%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 625,146
Bid Price 8.79
Ask Price 9.64
News -
Day High 9.07

Low
5.02

52 Week Range

High
17.7911

Day Low 8.51
Share Name Share Symbol Market Stock Type
Olema Pharmaceuticals Inc OLMA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.33 3.78% 9.06 19:00:00
Open Price Low Price High Price Close Price Previous Close
8.82 8.51 9.07 9.06 8.73
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
8,579 625,146 US$ 8.79 US$ 5,493,151 - 5.02 - 17.7911
Last Trade Type Quantity Price Currency
16:32:51 23 US$ 8.79 USD

Olema Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
506.59M 55.91M - 0 -96.66M -1.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Olema Pharmaceuticals News

Date Time Source News Article
5/15/202406:06Edgar (US Regulatory)Form 8-K - Current report
5/15/202406:01GlobeNewswire Inc.Olema Oncology Announces Promising New Data for Palazestrant..
5/08/202415:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202415:06Edgar (US Regulatory)Form 8-K - Current report
5/08/202415:02GlobeNewswire Inc.Olema Oncology Reports First Quarter 2024 Financial Results..
5/08/202406:02GlobeNewswire Inc.Olema Oncology Announces New Clinical Data for Palazestrant..
5/07/202416:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/06/202415:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/02/202415:37GlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq..
5/01/202406:02GlobeNewswire Inc.Olema Oncology to Participate in Upcoming Investor..
4/08/202415:30GlobeNewswire Inc.Olema Oncology to Participate in Canaccord Genuity 2024..
4/02/202415:29GlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OLMA Message Board. Create One! See More Posts on OLMA Message Board See More Message Board Posts

Historical OLMA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week9.7910.088.519.32547,811-0.73-7.46%
1 Month9.8711.408.519.96725,251-0.81-8.21%
3 Months12.6915.328.5111.10851,085-3.63-28.61%
6 Months13.6416.7758.5112.17873,348-4.58-33.58%
1 Year5.5417.79115.0211.84633,8223.5263.54%
3 Years25.0532.772.0011.27450,083-15.99-63.83%
5 Years47.0060.272.0012.90408,243-37.94-80.72%

Olema Pharmaceuticals Description

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250.

Your Recent History

Delayed Upgrade Clock